The global Friedreich Ataxia Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Friedreich Ataxia Drug production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Friedreich Ataxia Drug by regions (countries) and by Application.
The global Friedreich Ataxia Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Friedreich Ataxia Drug market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Friedreich Ataxia Drug markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Friedreich Ataxia Drug market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Friedreich Ataxia Drug market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Friedreich Ataxia Drug market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Friedreich Ataxia Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Friedreich Ataxia Drug market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Friedreich Ataxia Drug market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Friedreich Ataxia Drug market by each application segment for the same period.
This report includes the following manufacturers:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
Market Segment by Type
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Market Segment by Application
Clinic
Hospital
Others
Research Methodology
To compile the detailed study of the global Friedreich Ataxia Drug market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Friedreich Ataxia Drug market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Friedreich Ataxia Drug market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Friedreich Ataxia Drug production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Friedreich Ataxia Drug by regions (countries) and by Application.
The global Friedreich Ataxia Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Friedreich Ataxia Drug market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Friedreich Ataxia Drug markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Friedreich Ataxia Drug market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Friedreich Ataxia Drug market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Friedreich Ataxia Drug market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Friedreich Ataxia Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Friedreich Ataxia Drug market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Friedreich Ataxia Drug market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Friedreich Ataxia Drug market by each application segment for the same period.
This report includes the following manufacturers:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
Market Segment by Type
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Market Segment by Application
Clinic
Hospital
Others
Research Methodology
To compile the detailed study of the global Friedreich Ataxia Drug market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Friedreich Ataxia Drug market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Friedreich Ataxia Drug market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Type
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Friedreich Ataxia Drug Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Friedreich Ataxia Drug Market Size (2016-2027)
2.1.1 Global Friedreich Ataxia Drug Revenue (2016-2027)
2.1.2 Global Friedreich Ataxia Drug Sales (2016-2027)
2.2 Global Friedreich Ataxia Drug Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Friedreich Ataxia Drug Sales by Regions (2016-2021)
2.2.2 Global Friedreich Ataxia Drug Revenue by Regions (2016-2021)
2.3 Global Friedreich Ataxia Drug Market Size Forecast by Region
2.3.1 Global Friedreich Ataxia Drug Sales Forecast by Region (2022-2027)
2.3.2 Global Friedreich Ataxia Drug Revenue Forecast by Region (2022-2027)
2.4 Global Top Friedreich Ataxia Drug Regions (Countries) Ranking by Market Size
2.5 Friedreich Ataxia Drug Industry Trends
2.5.1 Friedreich Ataxia Drug Market Trends
2.5.2 Friedreich Ataxia Drug Market Drivers
2.5.3 Friedreich Ataxia Drug Market Challenges
2.5.4 Friedreich Ataxia Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Friedreich Ataxia Drug Manufacturers by Sales (2016-2021)
3.1.1 Global Friedreich Ataxia Drug Sales by Manufacturers (2016-2021)
3.1.2 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Friedreich Ataxia Drug Sales in 2020
3.2 Global Top Manufacturers Friedreich Ataxia Drug by Revenue
3.2.1 Global Friedreich Ataxia Drug Revenue by Manufacturers (2016-2021)
3.2.2 Top Friedreich Ataxia Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Friedreich Ataxia Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Friedreich Ataxia Drug as of 2020)
3.4 Global Friedreich Ataxia Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Friedreich Ataxia Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Friedreich Ataxia Drug Market
3.7 Key Manufacturers Friedreich Ataxia Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Friedreich Ataxia Drug Market Size by Type
4.1 Global Friedreich Ataxia Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Friedreich Ataxia Drug Revenue Market Share by Type (2016-2021)
4.1.3 Friedreich Ataxia Drug Price by Type (2016-2021)
4.2 Global Friedreich Ataxia Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Friedreich Ataxia Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Type (2022-2027)
4.2.3 Friedreich Ataxia Drug Price Forecast by Type (2022-2027)
5 Global Friedreich Ataxia Drug Market Size by Application
5.1 Global Friedreich Ataxia Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Friedreich Ataxia Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Friedreich Ataxia Drug Revenue Market Share by Application (2016-2021)
5.1.3 Friedreich Ataxia Drug Price by Application (2016-2021)
5.2 Global Friedreich Ataxia Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Friedreich Ataxia Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Application (2022-2027)
5.2.3 Friedreich Ataxia Drug Price Forecast by Application (2022-2027)
6 North America
6.1 North America Friedreich Ataxia Drug Sales Breakdown by Company
6.1.1 North America Friedreich Ataxia Drug Sales by Company (2016-2027)
6.1.2 North America Friedreich Ataxia Drug Revenue by Company (2016-2027)
6.2 North America Friedreich Ataxia Drug Market Size by Type (2016-2027)
6.2.1 North America Friedreich Ataxia Drug Sales by Type (2016-2027)
6.2.2 North America Friedreich Ataxia Drug Revenue by Type (2016-2027)
6.3 North America Friedreich Ataxia Drug Market Size by Application (2016-2027)
6.3.1 North America Friedreich Ataxia Drug Sales by Application (2016-2027)
6.3.2 North America Friedreich Ataxia Drug Revenue by Application (2016-2027)
6.4 North America Friedreich Ataxia Drug Market Size by Country
6.4.1 North America Friedreich Ataxia Drug Sales by Country (2016-2027)
6.4.2 North America Friedreich Ataxia Drug Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Friedreich Ataxia Drug Sales Breakdown by Company
7.1.1 Europe Friedreich Ataxia Drug Sales by Company (2016-2027)
7.1.2 Europe Friedreich Ataxia Drug Revenue by Company (2016-2027)
7.2 Europe Friedreich Ataxia Drug Market Size by Type (2016-2027)
7.2.1 Europe Friedreich Ataxia Drug Sales by Type (2016-2027)
7.2.2 Europe Friedreich Ataxia Drug Revenue by Type (2016-2027)
7.3 Europe Friedreich Ataxia Drug Market Size by Application (2016-2027)
7.3.1 Europe Friedreich Ataxia Drug Sales by Application (2016-2027)
7.3.2 Europe Friedreich Ataxia Drug Revenue by Application (2016-2027)
7.4 Europe Friedreich Ataxia Drug Market Size by Country
7.4.1 Europe Friedreich Ataxia Drug Sales by Country (2016-2027)
7.4.2 Europe Friedreich Ataxia Drug Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Friedreich Ataxia Drug Sales Breakdown by Company
8.1.1 Asia Pacific Friedreich Ataxia Drug Sales by Company (2016-2027)
8.1.2 Asia Pacific Friedreich Ataxia Drug Revenue by Company (2016-2027)
8.2 Asia Pacific Friedreich Ataxia Drug Market Size by Type (2016-2027)
8.2.1 Asia Pacific Friedreich Ataxia Drug Sales by Type (2016-2027)
8.2.2 Asia Pacific Friedreich Ataxia Drug Revenue by Type (2016-2027)
8.3 Asia Pacific Friedreich Ataxia Drug Market Size by Application (2016-2027)
8.3.1 Asia Pacific Friedreich Ataxia Drug Sales by Application (2016-2027)
8.3.2 Asia Pacific Friedreich Ataxia Drug Revenue by Application (2016-2027)
8.4 Asia Pacific Friedreich Ataxia Drug Market Size by Regions
8.4.1 Asia Pacific Friedreich Ataxia Drug Sales by Regions
8.4.2 Asia Pacific Friedreich Ataxia Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Friedreich Ataxia Drug Sales Breakdown by Company
9.1.1 Latin America Friedreich Ataxia Drug Sales by Company (2016-2027)
9.1.2 Latin America Friedreich Ataxia Drug Revenue by Company (2016-2027)
9.2 Latin America Friedreich Ataxia Drug Market Size by Type (2016-2027)
9.2.1 Latin America Friedreich Ataxia Drug Sales by Type (2016-2027)
9.2.2 Latin America Friedreich Ataxia Drug Revenue by Type (2016-2027)
9.3 Latin America Friedreich Ataxia Drug Market Size by Application (2016-2027)
9.3.1 Latin America Friedreich Ataxia Drug Sales by Application (2016-2027)
9.3.2 Latin America Friedreich Ataxia Drug Revenue by Application (2016-2027)
9.4 Latin America Friedreich Ataxia Drug Market Size by Country
9.4.1 Latin America Friedreich Ataxia Drug Sales by Country (2016-2027)
9.4.2 Latin America Friedreich Ataxia Drug Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Friedreich Ataxia Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Friedreich Ataxia Drug Sales by Company (2016-2027)
10.1.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Company (2016-2027)
10.2 Middle East and Africa Friedreich Ataxia Drug Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Friedreich Ataxia Drug Sales by Type (2016-2027)
10.2.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Type (2016-2027)
10.3 Middle East and Africa Friedreich Ataxia Drug Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Friedreich Ataxia Drug Sales by Application (2016-2027)
10.3.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Application (2016-2027)
10.4 Middle East and Africa Friedreich Ataxia Drug Market Size by Country
10.4.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country (2016-2027)
10.4.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Adverum Biotechnologies Inc
11.1.1 Adverum Biotechnologies Inc Corporation Information
11.1.2 Adverum Biotechnologies Inc Overview
11.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products and Services
11.1.5 Adverum Biotechnologies Inc Friedreich Ataxia Drug SWOT Analysis
11.1.6 Adverum Biotechnologies Inc Recent Developments
11.2 BioMarin Pharmaceutical Inc.
11.2.1 BioMarin Pharmaceutical Inc. Corporation Information
11.2.2 BioMarin Pharmaceutical Inc. Overview
11.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products and Services
11.2.5 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug SWOT Analysis
11.2.6 BioMarin Pharmaceutical Inc. Recent Developments
11.3 Biovista Inc.
11.3.1 Biovista Inc. Corporation Information
11.3.2 Biovista Inc. Overview
11.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Biovista Inc. Friedreich Ataxia Drug Products and Services
11.3.5 Biovista Inc. Friedreich Ataxia Drug SWOT Analysis
11.3.6 Biovista Inc. Recent Developments
11.4 Cardero Therapeutics Inc
11.4.1 Cardero Therapeutics Inc Corporation Information
11.4.2 Cardero Therapeutics Inc Overview
11.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.4.5 Cardero Therapeutics Inc Friedreich Ataxia Drug SWOT Analysis
11.4.6 Cardero Therapeutics Inc Recent Developments
11.5 Catabasis Pharmaceuticals, Inc.
11.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
11.5.2 Catabasis Pharmaceuticals, Inc. Overview
11.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products and Services
11.5.5 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug SWOT Analysis
11.5.6 Catabasis Pharmaceuticals, Inc. Recent Developments
11.6 Forward Pharma A/S
11.6.1 Forward Pharma A/S Corporation Information
11.6.2 Forward Pharma A/S Overview
11.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products and Services
11.6.5 Forward Pharma A/S Friedreich Ataxia Drug SWOT Analysis
11.6.6 Forward Pharma A/S Recent Developments
11.7 Ixchel Pharma LLC
11.7.1 Ixchel Pharma LLC Corporation Information
11.7.2 Ixchel Pharma LLC Overview
11.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products and Services
11.7.5 Ixchel Pharma LLC Friedreich Ataxia Drug SWOT Analysis
11.7.6 Ixchel Pharma LLC Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Overview
11.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Pfizer Inc Friedreich Ataxia Drug Products and Services
11.8.5 Pfizer Inc Friedreich Ataxia Drug SWOT Analysis
11.8.6 Pfizer Inc Recent Developments
11.9 ProQR Therapeutics NV
11.9.1 ProQR Therapeutics NV Corporation Information
11.9.2 ProQR Therapeutics NV Overview
11.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products and Services
11.9.5 ProQR Therapeutics NV Friedreich Ataxia Drug SWOT Analysis
11.9.6 ProQR Therapeutics NV Recent Developments
11.10 RaNA Therapeutics Inc
11.10.1 RaNA Therapeutics Inc Corporation Information
11.10.2 RaNA Therapeutics Inc Overview
11.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.10.5 RaNA Therapeutics Inc Friedreich Ataxia Drug SWOT Analysis
11.10.6 RaNA Therapeutics Inc Recent Developments
11.11 Reata Pharmaceuticals Inc
11.11.1 Reata Pharmaceuticals Inc Corporation Information
11.11.2 Reata Pharmaceuticals Inc Overview
11.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Products and Services
11.11.5 Reata Pharmaceuticals Inc Recent Developments
11.12 Retrotope Inc
11.12.1 Retrotope Inc Corporation Information
11.12.2 Retrotope Inc Overview
11.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Retrotope Inc Friedreich Ataxia Drug Products and Services
11.12.5 Retrotope Inc Recent Developments
11.13 Takeda
11.13.1 Takeda Corporation Information
11.13.2 Takeda Overview
11.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Takeda Friedreich Ataxia Drug Products and Services
11.13.5 Takeda Recent Developments
11.14 STATegics Inc
11.14.1 STATegics Inc Corporation Information
11.14.2 STATegics Inc Overview
11.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 STATegics Inc Friedreich Ataxia Drug Products and Services
11.14.5 STATegics Inc Recent Developments
11.15 Voyager Therapeutics Inc
11.15.1 Voyager Therapeutics Inc Corporation Information
11.15.2 Voyager Therapeutics Inc Overview
11.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.15.5 Voyager Therapeutics Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Friedreich Ataxia Drug Value Chain Analysis
12.2 Friedreich Ataxia Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Friedreich Ataxia Drug Production Mode & Process
12.4 Friedreich Ataxia Drug Sales and Marketing
12.4.1 Friedreich Ataxia Drug Sales Channels
12.4.2 Friedreich Ataxia Drug Distributors
12.5 Friedreich Ataxia Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Type
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Friedreich Ataxia Drug Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Friedreich Ataxia Drug Market Size (2016-2027)
2.1.1 Global Friedreich Ataxia Drug Revenue (2016-2027)
2.1.2 Global Friedreich Ataxia Drug Sales (2016-2027)
2.2 Global Friedreich Ataxia Drug Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Friedreich Ataxia Drug Sales by Regions (2016-2021)
2.2.2 Global Friedreich Ataxia Drug Revenue by Regions (2016-2021)
2.3 Global Friedreich Ataxia Drug Market Size Forecast by Region
2.3.1 Global Friedreich Ataxia Drug Sales Forecast by Region (2022-2027)
2.3.2 Global Friedreich Ataxia Drug Revenue Forecast by Region (2022-2027)
2.4 Global Top Friedreich Ataxia Drug Regions (Countries) Ranking by Market Size
2.5 Friedreich Ataxia Drug Industry Trends
2.5.1 Friedreich Ataxia Drug Market Trends
2.5.2 Friedreich Ataxia Drug Market Drivers
2.5.3 Friedreich Ataxia Drug Market Challenges
2.5.4 Friedreich Ataxia Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Friedreich Ataxia Drug Manufacturers by Sales (2016-2021)
3.1.1 Global Friedreich Ataxia Drug Sales by Manufacturers (2016-2021)
3.1.2 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Friedreich Ataxia Drug Sales in 2020
3.2 Global Top Manufacturers Friedreich Ataxia Drug by Revenue
3.2.1 Global Friedreich Ataxia Drug Revenue by Manufacturers (2016-2021)
3.2.2 Top Friedreich Ataxia Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Friedreich Ataxia Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Friedreich Ataxia Drug as of 2020)
3.4 Global Friedreich Ataxia Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Friedreich Ataxia Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Friedreich Ataxia Drug Market
3.7 Key Manufacturers Friedreich Ataxia Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Friedreich Ataxia Drug Market Size by Type
4.1 Global Friedreich Ataxia Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Friedreich Ataxia Drug Revenue Market Share by Type (2016-2021)
4.1.3 Friedreich Ataxia Drug Price by Type (2016-2021)
4.2 Global Friedreich Ataxia Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Friedreich Ataxia Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Type (2022-2027)
4.2.3 Friedreich Ataxia Drug Price Forecast by Type (2022-2027)
5 Global Friedreich Ataxia Drug Market Size by Application
5.1 Global Friedreich Ataxia Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Friedreich Ataxia Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Friedreich Ataxia Drug Revenue Market Share by Application (2016-2021)
5.1.3 Friedreich Ataxia Drug Price by Application (2016-2021)
5.2 Global Friedreich Ataxia Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Friedreich Ataxia Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Application (2022-2027)
5.2.3 Friedreich Ataxia Drug Price Forecast by Application (2022-2027)
6 North America
6.1 North America Friedreich Ataxia Drug Sales Breakdown by Company
6.1.1 North America Friedreich Ataxia Drug Sales by Company (2016-2027)
6.1.2 North America Friedreich Ataxia Drug Revenue by Company (2016-2027)
6.2 North America Friedreich Ataxia Drug Market Size by Type (2016-2027)
6.2.1 North America Friedreich Ataxia Drug Sales by Type (2016-2027)
6.2.2 North America Friedreich Ataxia Drug Revenue by Type (2016-2027)
6.3 North America Friedreich Ataxia Drug Market Size by Application (2016-2027)
6.3.1 North America Friedreich Ataxia Drug Sales by Application (2016-2027)
6.3.2 North America Friedreich Ataxia Drug Revenue by Application (2016-2027)
6.4 North America Friedreich Ataxia Drug Market Size by Country
6.4.1 North America Friedreich Ataxia Drug Sales by Country (2016-2027)
6.4.2 North America Friedreich Ataxia Drug Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Friedreich Ataxia Drug Sales Breakdown by Company
7.1.1 Europe Friedreich Ataxia Drug Sales by Company (2016-2027)
7.1.2 Europe Friedreich Ataxia Drug Revenue by Company (2016-2027)
7.2 Europe Friedreich Ataxia Drug Market Size by Type (2016-2027)
7.2.1 Europe Friedreich Ataxia Drug Sales by Type (2016-2027)
7.2.2 Europe Friedreich Ataxia Drug Revenue by Type (2016-2027)
7.3 Europe Friedreich Ataxia Drug Market Size by Application (2016-2027)
7.3.1 Europe Friedreich Ataxia Drug Sales by Application (2016-2027)
7.3.2 Europe Friedreich Ataxia Drug Revenue by Application (2016-2027)
7.4 Europe Friedreich Ataxia Drug Market Size by Country
7.4.1 Europe Friedreich Ataxia Drug Sales by Country (2016-2027)
7.4.2 Europe Friedreich Ataxia Drug Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Friedreich Ataxia Drug Sales Breakdown by Company
8.1.1 Asia Pacific Friedreich Ataxia Drug Sales by Company (2016-2027)
8.1.2 Asia Pacific Friedreich Ataxia Drug Revenue by Company (2016-2027)
8.2 Asia Pacific Friedreich Ataxia Drug Market Size by Type (2016-2027)
8.2.1 Asia Pacific Friedreich Ataxia Drug Sales by Type (2016-2027)
8.2.2 Asia Pacific Friedreich Ataxia Drug Revenue by Type (2016-2027)
8.3 Asia Pacific Friedreich Ataxia Drug Market Size by Application (2016-2027)
8.3.1 Asia Pacific Friedreich Ataxia Drug Sales by Application (2016-2027)
8.3.2 Asia Pacific Friedreich Ataxia Drug Revenue by Application (2016-2027)
8.4 Asia Pacific Friedreich Ataxia Drug Market Size by Regions
8.4.1 Asia Pacific Friedreich Ataxia Drug Sales by Regions
8.4.2 Asia Pacific Friedreich Ataxia Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Friedreich Ataxia Drug Sales Breakdown by Company
9.1.1 Latin America Friedreich Ataxia Drug Sales by Company (2016-2027)
9.1.2 Latin America Friedreich Ataxia Drug Revenue by Company (2016-2027)
9.2 Latin America Friedreich Ataxia Drug Market Size by Type (2016-2027)
9.2.1 Latin America Friedreich Ataxia Drug Sales by Type (2016-2027)
9.2.2 Latin America Friedreich Ataxia Drug Revenue by Type (2016-2027)
9.3 Latin America Friedreich Ataxia Drug Market Size by Application (2016-2027)
9.3.1 Latin America Friedreich Ataxia Drug Sales by Application (2016-2027)
9.3.2 Latin America Friedreich Ataxia Drug Revenue by Application (2016-2027)
9.4 Latin America Friedreich Ataxia Drug Market Size by Country
9.4.1 Latin America Friedreich Ataxia Drug Sales by Country (2016-2027)
9.4.2 Latin America Friedreich Ataxia Drug Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Friedreich Ataxia Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Friedreich Ataxia Drug Sales by Company (2016-2027)
10.1.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Company (2016-2027)
10.2 Middle East and Africa Friedreich Ataxia Drug Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Friedreich Ataxia Drug Sales by Type (2016-2027)
10.2.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Type (2016-2027)
10.3 Middle East and Africa Friedreich Ataxia Drug Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Friedreich Ataxia Drug Sales by Application (2016-2027)
10.3.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Application (2016-2027)
10.4 Middle East and Africa Friedreich Ataxia Drug Market Size by Country
10.4.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country (2016-2027)
10.4.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Adverum Biotechnologies Inc
11.1.1 Adverum Biotechnologies Inc Corporation Information
11.1.2 Adverum Biotechnologies Inc Overview
11.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products and Services
11.1.5 Adverum Biotechnologies Inc Friedreich Ataxia Drug SWOT Analysis
11.1.6 Adverum Biotechnologies Inc Recent Developments
11.2 BioMarin Pharmaceutical Inc.
11.2.1 BioMarin Pharmaceutical Inc. Corporation Information
11.2.2 BioMarin Pharmaceutical Inc. Overview
11.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products and Services
11.2.5 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug SWOT Analysis
11.2.6 BioMarin Pharmaceutical Inc. Recent Developments
11.3 Biovista Inc.
11.3.1 Biovista Inc. Corporation Information
11.3.2 Biovista Inc. Overview
11.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Biovista Inc. Friedreich Ataxia Drug Products and Services
11.3.5 Biovista Inc. Friedreich Ataxia Drug SWOT Analysis
11.3.6 Biovista Inc. Recent Developments
11.4 Cardero Therapeutics Inc
11.4.1 Cardero Therapeutics Inc Corporation Information
11.4.2 Cardero Therapeutics Inc Overview
11.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.4.5 Cardero Therapeutics Inc Friedreich Ataxia Drug SWOT Analysis
11.4.6 Cardero Therapeutics Inc Recent Developments
11.5 Catabasis Pharmaceuticals, Inc.
11.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
11.5.2 Catabasis Pharmaceuticals, Inc. Overview
11.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products and Services
11.5.5 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug SWOT Analysis
11.5.6 Catabasis Pharmaceuticals, Inc. Recent Developments
11.6 Forward Pharma A/S
11.6.1 Forward Pharma A/S Corporation Information
11.6.2 Forward Pharma A/S Overview
11.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products and Services
11.6.5 Forward Pharma A/S Friedreich Ataxia Drug SWOT Analysis
11.6.6 Forward Pharma A/S Recent Developments
11.7 Ixchel Pharma LLC
11.7.1 Ixchel Pharma LLC Corporation Information
11.7.2 Ixchel Pharma LLC Overview
11.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products and Services
11.7.5 Ixchel Pharma LLC Friedreich Ataxia Drug SWOT Analysis
11.7.6 Ixchel Pharma LLC Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Overview
11.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Pfizer Inc Friedreich Ataxia Drug Products and Services
11.8.5 Pfizer Inc Friedreich Ataxia Drug SWOT Analysis
11.8.6 Pfizer Inc Recent Developments
11.9 ProQR Therapeutics NV
11.9.1 ProQR Therapeutics NV Corporation Information
11.9.2 ProQR Therapeutics NV Overview
11.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products and Services
11.9.5 ProQR Therapeutics NV Friedreich Ataxia Drug SWOT Analysis
11.9.6 ProQR Therapeutics NV Recent Developments
11.10 RaNA Therapeutics Inc
11.10.1 RaNA Therapeutics Inc Corporation Information
11.10.2 RaNA Therapeutics Inc Overview
11.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.10.5 RaNA Therapeutics Inc Friedreich Ataxia Drug SWOT Analysis
11.10.6 RaNA Therapeutics Inc Recent Developments
11.11 Reata Pharmaceuticals Inc
11.11.1 Reata Pharmaceuticals Inc Corporation Information
11.11.2 Reata Pharmaceuticals Inc Overview
11.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Products and Services
11.11.5 Reata Pharmaceuticals Inc Recent Developments
11.12 Retrotope Inc
11.12.1 Retrotope Inc Corporation Information
11.12.2 Retrotope Inc Overview
11.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Retrotope Inc Friedreich Ataxia Drug Products and Services
11.12.5 Retrotope Inc Recent Developments
11.13 Takeda
11.13.1 Takeda Corporation Information
11.13.2 Takeda Overview
11.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Takeda Friedreich Ataxia Drug Products and Services
11.13.5 Takeda Recent Developments
11.14 STATegics Inc
11.14.1 STATegics Inc Corporation Information
11.14.2 STATegics Inc Overview
11.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 STATegics Inc Friedreich Ataxia Drug Products and Services
11.14.5 STATegics Inc Recent Developments
11.15 Voyager Therapeutics Inc
11.15.1 Voyager Therapeutics Inc Corporation Information
11.15.2 Voyager Therapeutics Inc Overview
11.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Products and Services
11.15.5 Voyager Therapeutics Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Friedreich Ataxia Drug Value Chain Analysis
12.2 Friedreich Ataxia Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Friedreich Ataxia Drug Production Mode & Process
12.4 Friedreich Ataxia Drug Sales and Marketing
12.4.1 Friedreich Ataxia Drug Sales Channels
12.4.2 Friedreich Ataxia Drug Distributors
12.5 Friedreich Ataxia Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
